MetLife Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $949K | Sell |
|
|||||
|
2025
Q2 | $732K | Hold |
|
|||||
|
2025
Q1 | $751K | Sell |
|
|||||
|
2024
Q4 | $630K | Buy |
|
|||||
|
2024
Q3 | $640K | Hold |
|
|||||
|
2024
Q2 | $683K | Buy |
|
|||||
|
2024
Q1 | $531K | Hold |
|
|||||
|
2023
Q4 | $423K | Hold |
|
|||||
|
2023
Q3 | $446K | Buy |
|
|||||
|
2023
Q2 | $362K | Hold |
|
|||||
|
2023
Q1 | $267K | Buy |
|
|||||
|
2022
Q4 | $259K | Buy |
|
|||||
|
2022
Q3 | $188K | Hold |
|
|||||
|
2022
Q2 | $174K | Hold |
|
|||||
|
2022
Q1 | $165K | Buy |
|
|||||
|
2021
Q4 | $172K | Hold |
|
|||||
|
2021
Q3 | $122K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $115K | Hold |
|
|||||
|
2020
Q3 | $111K | Hold |
|
|||||
|
2020
Q2 | $128K | Hold |
|
|||||
|
2020
Q1 | $161K | Hold |
|
|||||
|
2019
Q4 | $243K | Hold |
|
|||||
|
2019
Q3 | $288K | Hold |
|
|||||
|
2019
Q2 | $324K | Hold |
|
|||||
|
2019
Q1 | $278K | Hold |
|
|||||
|
2018
Q4 | $178K | Hold |
|
|||||
|
2018
Q3 | $223K | Hold |
|
|||||
|
2018
Q2 | $264K | Hold |
|
|||||
|
2018
Q1 | $230K | Hold |
|
|||||
|
2017
Q4 | $254K | Buy |
|